Axsome Therapeutics Inc (AXSM)
71.17
-1.91
(-2.61%)
USD |
NASDAQ |
Apr 24, 16:00
71.21
+0.04
(+0.06%)
Pre-Market: 20:00
Axsome Therapeutics Shareholders Equity (Quarterly): 190.98M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 190.98M |
| September 30, 2023 | 269.51M |
| June 30, 2023 | 278.80M |
| March 31, 2023 | 111.81M |
| December 31, 2022 | 109.56M |
| September 30, 2022 | 157.36M |
| June 30, 2022 | 15.20M |
| March 31, 2022 | 14.70M |
| December 31, 2021 | 15.63M |
| September 30, 2021 | 42.72M |
| June 30, 2021 | 71.44M |
| March 31, 2021 | 96.29M |
| December 31, 2020 | 113.79M |
| September 30, 2020 | 135.26M |
| June 30, 2020 | 154.24M |
| March 31, 2020 | 156.16M |
| December 31, 2019 | 178.72M |
| September 30, 2019 | 6.823M |
| Date | Value |
|---|---|
| June 30, 2019 | 24.28M |
| March 31, 2019 | 17.37M |
| December 31, 2018 | 0.9379M |
| September 30, 2018 | 0.7428M |
| June 30, 2018 | 7.009M |
| March 31, 2018 | 12.59M |
| December 31, 2017 | 16.72M |
| September 30, 2017 | 16.84M |
| June 30, 2017 | 22.75M |
| March 31, 2017 | 29.28M |
| December 31, 2016 | 21.57M |
| September 30, 2016 | 28.18M |
| June 30, 2016 | 34.90M |
| March 31, 2016 | 41.23M |
| December 31, 2015 | 46.44M |
| September 30, 2015 | 3.904M |
| June 30, 2015 | -7.212M |
| December 31, 2014 | -3.203M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
6.823M
Minimum
Sep 2019
278.80M
Maximum
Jun 2023
112.80M
Average
111.81M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Amgen Inc | 6.232B |
| Johnson & Johnson | 68.77B |
| ResMed Inc | 4.482B |
| Vertex Pharmaceuticals Inc | 17.58B |
| Krystal Biotech Inc | 778.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 588.24M |
| Total Liabilities (Quarterly) | 397.26M |
| Debt to Equity Ratio | 0.9324 |
| Current Ratio | 3.632 |
| Net Debt Paydown Yield | -0.45% |